News

XMT-1522 is based on the company’s Fleximer immunoconjugate technology that carries an average of 15 proprietary auristatin payload molecules. Optimized for payload delivery, the conjugate uses a new

Several patients with stage IIb to IV malignant melanoma develop cutaneous metastases and samcyprone is being developed to treat these metastases. Samcyprone is a topical formulation of Diphenylcylcopropenone

Earlier, Keytruda received breakthrough therapy designation for advanced NSCLC and this sBLA seeks approval to treat these NSCLC patients whose disease has progressed on or after platinum-containing chemotherapy

In uveal melanoma, cancer cells form in the tissues of the eye and it is the most common primary intraocular malignancy in adults and comprises 5% of all

Around 24-30 patients will be enrolled in the first-in-human trial, which will be conducted at the University Hospitals of Mainz and Tuebingen in Germany. The trial will evaluate

The US Food and Drug Administration (FDA) has granted approval for Sandoz’s Glatopa, the first generic version of Teva’s Copaxone (glatiramer acetate injection) 20mg/ml one-time-daily multiple sclerosis (MS)

The deal aims at the development of a joint project, based on new findings by professor Aaron Ciechanover, Dr Gila Maor and professor Ofer Binah, that can potentially

As part of the deal, BMS has transferred full commercialization and manufacturing operational responsibilities to Lilly. The companies’ decision comes after a 14-year successful collaboration, which includes ImClone,

The Takeda-CiRA (T-CiRA) joint program is designed to expedite multiple research projects for drug discovery and cell therapy using iPS cells. As part of the deal, CiRA director